ANRO vs CDW · $60.1M cap vs P/E 22, rev $21.00B
Alto Neuroscience, Inc. (ANRO) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
CDW Corp (CDW) is a information technology services company listed on US.
ANRO does not have a complete income-statement cache yet.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
ANRO currently screens at market cap $60.1M. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the ANRO and CDW stock pages for the full models.
Not investment advice.